Commodore Capital is invested in the early stages of a major innovation cycle in biopharmaceuticals.
Commodore Capital is invested in the early stages of a major innovation cycle in biopharmaceuticals.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jul 13, 2021
Nimbus Therapeutics
|
Series Unknown | $105M | Biotechnology | — |